{"id":237285,"date":"2024-03-19T10:04:05","date_gmt":"2024-03-19T09:04:05","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=237285"},"modified":"2024-06-07T09:52:13","modified_gmt":"2024-06-07T07:52:13","slug":"assessor-respon-comentari-sentencia-tjue-cas-doctipharma","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/","title":{"rendered":"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma"},"content":{"rendered":"\n

Relativa a les plataformes d’internet per les que es posen en contacte oficines de farm\u00e0cia i clients<\/strong><\/h2>\n\n\n\n

El passat 29 de febrer d\u2019enguany es va dictar pel Tribunal de Just\u00edcia de la Uni\u00f3 Europea (Sala Segona), la Sent\u00e8ncia corresponent a l\u2019assumpte C-606\/21, per la que es resolia una q\u00fcesti\u00f3 prejudicial presentada per la Cour d\u2019Appel de Par\u00eds amb relaci\u00f3 a l\u2019anomenat \u201ccas Doctipharma\u201d). A grans trets, la q\u00fcesti\u00f3 controvertida de fons radicava en determinar la compatibilitat amb el Dret Comunitari (i en concret, amb la Directiva 2011\/62, per la que es modific\u00e0 la Directiva 2001\/83\/CE, per la que s’establ\u00ed un codi comunitari sobre medicaments d\u2019\u00fas hum\u00e0, pel que fa a la prevenci\u00f3 de l\u2019entrada de medicaments falsificats a la cadena de subministrament legal), de la plataforma online de titularitat de l\u2019empresa Doctipharma. La funcionalitat d\u2019aquesta plataforma consisteix a posar en contacte oficines de farm\u00e0cia (que s\u2019han de donar d\u2019alta a la plataforma, previ pagament) i persones f\u00edsiques potencials compradores de medicaments no subjectes a recepta m\u00e8dica.<\/p>\n\n\n\n

Respecte de la q\u00fcesti\u00f3 controvertida, el TJUE conclou que la funcionalitat de l\u2019esmentada plataforma no s\u2019oposa a la Directiva 2011\/62 (en concret, a l’article 85, pel qual s\u2019estableixen les condicions a partir de les quals els estats membres poden restringir les vendes de medicaments OTC a uns determinants col\u00b7lectius en possessi\u00f3 de determinades qualificacions professionals), sempre que el Tribunal nacional que estigui coneixent del litigi principal (en aquest cas, la Cour d\u2019Appel de Par\u00eds) no conclogui, tenint en compte els fets concrets del cas, que Doctipharma presta un servei de venda de medicaments per ella mateixa (ja fos aquest prestat de forma directa per Doctipharma, o de forma indirecta a trav\u00e9s de les oficines de farm\u00e0cia que s\u2019han donat d\u2019alta a la seva plataforma, previ pagament).<\/p>\n\n\n\n

En definitiva, en virtut de la Sent\u00e8ncia aqu\u00ed comentada, el TJUE reafirma la facultat dels estats membres de restringir la venda de medicaments online a col\u00b7lectius en possessi\u00f3 de determinades qualificacions professionals (fonamentalment, els farmac\u00e8utics), podent, per tant, els estats prohibir la venda de medicaments OTC per mitjans telem\u00e0tics a empreses i\/o persones alienes a aquests col\u00b7lectius restringits. No obstant aix\u00f2, delega en els Tribunals estatals que estiguin coneixent dels litigis concrets, la determinaci\u00f3 de si una determinada plataforma que actua online per posar en contacte oficines de farm\u00e0cia i clients  efectua per ella mateixa la venda medicaments OTC (essent que, en aquest cas, la seva activitat podria prohibir-se pels estats membres) o no.<\/p>\n\n\n\n

Caldr\u00e0 doncs estar atent a la Sent\u00e8ncia que es dicti per la Cour d\u2019Appel francesa en el cas Doctipiharma, si b\u00e9 els criteris que pugui sentar aquesta no seran directament traslladables a l\u2019Estat espanyol (atesa les difer\u00e8ncies entre la legislaci\u00f3 espanyola i francesa en mat\u00e8ria de venda de medicaments OTC).<\/p>\n\n\n\n

A Barcelona, a 11 de mar\u00e7 de 2024.<\/p>\n\n\n\n

Roger Canals Vaquer<\/p>\n\n\n\n

Responsable del Departament de Dret Administratiu<\/p>\n\n\n\n

ARCO ABOGADOS Y ASESORES TRIBUTARIOS, S.L.P.  <\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Amb la col\u00b7laboraci\u00f3 de:<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

El passat 29 de febrer d\u2019enguany es va dictar pel Tribunal de Just\u00edcia de la Uni\u00f3 Europea (Sala Segona), la Sent\u00e8ncia corresponent a l\u2019assumpte C-606\/21, per la que es resolia una q\u00fcesti\u00f3 prejudicial presentada per la Cour d\u2019Appel de Par\u00eds amb relaci\u00f3 a l\u2019anomenat \u201ccas Doctipharma\u201d). A grans trets, la q\u00fcesti\u00f3 controvertida de fons radicava en determinar la compatibilitat amb el Dret Comunitari (i en concret, amb la Directiva 2011\/62, per la que es modific\u00e0 la Directiva 2001\/83\/CE, per la que s’establ\u00ed un codi comunitari sobre medicaments d\u2019\u00fas hum\u00e0, pel que fa a la prevenci\u00f3 de l\u2019entrada de medicaments falsificats a la cadena de subministrament legal), de la plataforma online de titularitat de l\u2019empresa Doctipharma. La funcionalitat d\u2019aquesta plataforma consisteix a posar en contacte oficines de farm\u00e0cia (que s\u2019han de donar d\u2019alta a la plataforma, previ pagament) i persones f\u00edsiques potencials compradores de medicaments no subjectes a recepta m\u00e8dica.<\/p>\n","protected":false},"author":2313,"featured_media":237286,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2066,190,293,474,10,11,12,13,14,15,294,2165,251,101],"tags":[107,136,279,484,2687,2688],"class_list":["post-237285","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-lassessor-respon","category-gestio","category-eines-digitals-per-a-la-farmacia","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-politica-sanitaria","category-proveidors","category-reflexions-de-junta","category-sanitaria","tag-medicaments-falsificats","tag-medicaments","tag-otc","tag-venda-online","tag-doctipharma","tag-plataforma-online"],"yoast_head":"\nL\u2019Assessor Respon: comentari sent\u00e8ncia TJUE cas Doctipharma<\/title>\n<meta name=\"description\" content=\"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma - ARCO ABOGADOS Y ASESORES TRIBUTARIOS, S.L.P. \u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019Assessor Respon: comentari sent\u00e8ncia TJUE cas Doctipharma\" \/>\n<meta property=\"og:description\" content=\"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma - ARCO ABOGADOS Y ASESORES TRIBUTARIOS, S.L.P. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-19T09:04:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-07T07:52:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/doctipharma-assessor-respon.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1366\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma\",\"datePublished\":\"2024-03-19T09:04:05+00:00\",\"dateModified\":\"2024-06-07T07:52:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/\"},\"wordCount\":541,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctipharma-assessor-respon.jpg\",\"keywords\":[\"medicaments falsificats\",\"medicaments\",\"OTC\",\"venda online\",\"Doctipharma\",\"plataforma online\"],\"articleSection\":[\"Actualitat\",\"L\u2019assessor respon\",\"Gesti\u00f3\",\"Eines digitals per a la farm\u00e0cia\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Pol\u00edtica sanit\u00e0ria\",\"Prove\u00efdors\",\"Reflexions de Junta\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/\",\"name\":\"L\u2019Assessor Respon: comentari sent\u00e8ncia TJUE cas Doctipharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctipharma-assessor-respon.jpg\",\"datePublished\":\"2024-03-19T09:04:05+00:00\",\"dateModified\":\"2024-06-07T07:52:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma - ARCO ABOGADOS Y ASESORES TRIBUTARIOS, S.L.P. \u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctipharma-assessor-respon.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctipharma-assessor-respon.jpg\",\"width\":1366,\"height\":768,\"caption\":\"Law flat icon with modern laptop computer on wooden table over blur light and shadow of shopping mall, Business legal service online concept\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019Assessor Respon: comentari sent\u00e8ncia TJUE cas Doctipharma","description":"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma - ARCO ABOGADOS Y ASESORES TRIBUTARIOS, S.L.P. \u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/","og_locale":"ca_ES","og_type":"article","og_title":"L\u2019Assessor Respon: comentari sent\u00e8ncia TJUE cas Doctipharma","og_description":"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma - ARCO ABOGADOS Y ASESORES TRIBUTARIOS, S.L.P. \u00a0","og_url":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/","og_site_name":"FEFAC","article_published_time":"2024-03-19T09:04:05+00:00","article_modified_time":"2024-06-07T07:52:13+00:00","og_image":[{"width":1366,"height":768,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/doctipharma-assessor-respon.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma","datePublished":"2024-03-19T09:04:05+00:00","dateModified":"2024-06-07T07:52:13+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/"},"wordCount":541,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/doctipharma-assessor-respon.jpg","keywords":["medicaments falsificats","medicaments","OTC","venda online","Doctipharma","plataforma online"],"articleSection":["Actualitat","L\u2019assessor respon","Gesti\u00f3","Eines digitals per a la farm\u00e0cia","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","Pol\u00edtica sanit\u00e0ria","Prove\u00efdors","Reflexions de Junta","Sanit\u00e0ria"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/","url":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/","name":"L\u2019Assessor Respon: comentari sent\u00e8ncia TJUE cas Doctipharma","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/doctipharma-assessor-respon.jpg","datePublished":"2024-03-19T09:04:05+00:00","dateModified":"2024-06-07T07:52:13+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma - ARCO ABOGADOS Y ASESORES TRIBUTARIOS, S.L.P. \u00a0","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/doctipharma-assessor-respon.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/doctipharma-assessor-respon.jpg","width":1366,"height":768,"caption":"Law flat icon with modern laptop computer on wooden table over blur light and shadow of shopping mall, Business legal service online concept"},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/assessor-respon-comentari-sentencia-tjue-cas-doctipharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"L\u2019Assessor Respon: comentari a la sent\u00e8ncia del TJUE en el cas Doctipharma"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=237285"}],"version-history":[{"count":2,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237285\/revisions"}],"predecessor-version":[{"id":238560,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237285\/revisions\/238560"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/237286"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=237285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=237285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=237285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}